U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H17ClF2N4O3
Molecular Weight 410.802
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JNJ-42165279

SMILES

FC1(F)OC2=CC=C(CN3CCN(CC3)C(=O)NC4=C(Cl)C=CN=C4)C=C2O1

InChI

InChIKey=YWGYNGCRVZLMCS-UHFFFAOYSA-N
InChI=1S/C18H17ClF2N4O3/c19-13-3-4-22-10-14(13)23-17(26)25-7-5-24(6-8-25)11-12-1-2-15-16(9-12)28-18(20,21)27-15/h1-4,9-10H,5-8,11H2,(H,23,26)

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
70.0 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.
2015 Dec 10
Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.
2018 Jul
Patents

Patents

Name Type Language
JNJ-42165279
Common Name English
1-PIPERAZINECARBOXAMIDE, N-(4-CHLORO-3-PYRIDINYL)-4-((2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
54576693
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY
FDA UNII
AH2E5UQ11Y
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY
CAS
1346528-50-4
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY
WIKIPEDIA
JNJ-42165279
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY
DRUG BANK
DB15173
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY
EPA CompTox
DTXSID501045937
Created by admin on Sat Dec 16 01:56:38 GMT 2023 , Edited by admin on Sat Dec 16 01:56:38 GMT 2023
PRIMARY